Position in A
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,718,421
+$287,859 QoQ
Shares Held
12,937
+3.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#422
of 1,112 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 12%
Shared 0%
None 88%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Pallas Capital Advisors LLC holds $18,791,753 across 11 Diagnostics & Research names. A ranks #4 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
10,365 | $5,196,596 | |
| 2 | ILMN |
Illumina, Inc.
|
25,513 | $4,485,950 | |
| 3 | NTRA |
Natera, Inc.
|
9,853 | $2,674,596 | |
| 4 | A |
Agilent Technologies, Inc.
This page
|
12,937 | $1,718,421 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
8,032 | $1,551,943 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
2,142 | $1,134,381 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
1,476 | $777,025 | |
| 8 | DHR |
Danaher Corp /De/
|
3,367 | $641,346 |
All Filings in A
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,718,421 | 12,937 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,430,562 | 12,551 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,961,176 | 14,413 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,849,651 | 14,411 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,983,512 | 16,808 | Shares | Sole | 2025-07-09 | |
| No filing history on record for this holder in this stock. | ||||||